03-Nov-2026 21:22:35
ADVENZYMESExpansion
ADVANCED ENZYME TECHNOLOGIES Q2 FY27 CONCALL: TARGETS LOWER-MID DOUBLE-DIGIT FY27 REVENUE GROWTH & 30–32% EBITDA MARGIN; ₹123 CR CAPEX PLANNED, US MARKET RECOVERY EXPECTED IN 1–2 QUARTERS
ADVANCED ENZYME TECH LTD